Publications by authors named "Joseph Dillon"

Claim this Profile
R
Risk Factors and Prognosis of Peritoneal Metastases in Small Bowel Neuroendocrine Tumor Patients.
Jeremy Chang, Luis C Borbon, Scott K Sherman, Po Hien Ear, Andrew M Bellizzi, Joseph S Dillon

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Visual Abstract: Risk Factors and Prognosis of Peritoneal Metastases in Small Bowel Neuroendocrine Tumor Patients.
Jeremy Chang, Luis C Borbon, Scott K Sherman, Po Hien Ear, Andrew M Bellizzi, Joseph S Dillon

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: The Challenge of Peritoneal Metastases in Patients with Small Bowel Neuroendocrine Tumors.
Jeremy Chang, Luis C Borbon, Scott K Sherman, Po Hien Ear, Andrew M Bellizzi, Joseph S Dillon

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.
Tao Xu, Joseph S Dillon, Dawn E Quelle, Sarah H Nash, Hyunkeun Cho

Cancer Epidemiol Biomarkers Prev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors.
Jonathan S Shilyansky, Casandro J Chan, Sophia Xiao, Irena Gribovskaja-Rupp, Dawn E Quelle, Joseph S Dillon

Surgery· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.
Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda, Joseph S Dillon

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs.
James R Howe, Scott K Sherman, Joseph S Dillon

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The University of Iowa Neuroendocrine Tumor Clinic.
James R Howe, Yusuf Menda, Chandrikha Chandrasekharan, Andrew M Bellizzi, Dawn E Quelle, Joseph S Dillon

Endocr Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies.
Po Hien Ear, Sophia A Hueser, Reese E Townsend, Jessica E Maxwell, Ellen Abusada, Joseph S Dillon

Endocr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.
Tao Xu, Joseph S Dillon, Mary A Maluccio, Dawn E Quelle, Sarah H Nash

J Cancer Res Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and intra-tumoral heterogeneity on [Ga]Ga-DOTA-TATE/[Ga]Ga-DOTA-TOC PET/CT predicts response to [Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients.
Camila Gadens Zamboni, Ayca Dundar, Sanchay Jain, Marc Kruzer, Bradley T Loeffler, Joseph S Dillon

EJNMMI Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of functional neuroendocrine tumors.
Amr Wahba, Zi Tan, Joseph S Dillon

Curr Probl Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: A NET Center of Excellence Experience.
Udhayvir S Grewal, Bradley T Loeffler, Alexander Paschke, Joseph S Dillon, Chandrikha Chandrasekharan

J Gastrointest Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for carcinoid heart disease: Trends and future Perspectives.
Bryan Mouser, James R Howe, Olivia Atari, Joseph S Dillon, Chandrikha Chandrasekharan

Int J Cardiol Cardiovasc Risk Prev· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Assembled Plasmonic Structural Color Colorimetric Sensor for Smartphone-Based Point-Of-Care Ammonia Detection in Water.
Mahdi Soudi, Pablo Cencillo-Abad, Jay Patel, Suvash Ghimire, Joseph Dillon

ACS Appl Mater Interfaces· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth .
Dane H Tow, Catherine G Tran, Luis C Borbon, Maclain Ridder, Guiying Li, Joseph Dillon

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.
Camilo Jimenez, Bennett B Chin, Richard B Noto, Joseph S Dillon, Lilja Solnes

Endocr Relat Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Surgical Resection Should be Considered in the Multidisciplinary Care of Patients with Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms.
Ioannis A Ziogas, Joseph S Dillon, Chandrikha Chandrasekharan, James R Howe

Ann Surg Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis.
Ioannis A Ziogas, Panagiotis T Tasoudis, Luis C Borbon, Scott K Sherman, Patrick J Breheny, Joseph S Dillon

Ann Surg Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Luis C Borbon, Catherine G Tran, Scott K Sherman, Po Hien Ear, Chandrikha Chandrasekharan, Joseph S Dillon

Ann Surg Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.
Catherine G Tran, Scott K Sherman, Mohammed O Suraju, Apoorve Nayyar, Henning Gerke, Joseph S Dillon

Ann Surg Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia secondary to insulinoma masking the onset of type 1 diabetes in an adolescent.
Sriya Subramani, Andrew M Bellizzi, Nicholas Borcherding, Simon C Kao, Joseph Dillon

Clin Case Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Specific-Activity-I-MIBG versus Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.
Abhishek Jha, David Taïeb, Jorge A Carrasquillo, Daniel A Pryma, Mayank Patel, Joseph S Dillon

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presacral neuroendocrine tumors associated with the Currarino syndrome.
Aaron T Scott, Jonathon B Tessmann, Terry Braun, Bartley Brown, Patrick J Breheny, Joseph S Dillon

Am J Med Genet A· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-specific-activity iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.
Joseph S Dillon, David Bushnell, Douglas E Laux

Future Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis